Wegovy found to have ‘quite profound’ effect on reducing risk of heart attacks, says pharma group
Novo Nordisk’s obesity drug cuts risk of death by 18%, trial data shows
Recent Posts
- Gold-rich Nicaragua hands Chinese miners rights to a tenth of its land
- The executives going ‘fractional’, not freelance
- De Beers bets on a taste for the real to restore diamonds’ sparkle
- US housing crunch puts private equity in midterm campaign crosshairs
- Trump and Xi to meet twice more after summit fails to resolve tensions
